Over two-thirds of biopharmaceutical manufacturers now report that their facility is experiencing capacity bottlenecks due to downstream processing. A number of factors continue to converge to create ...

After upstream bioprocessing, such as developing a cell line or microorganism that can produce an intended product, a bioprocessor turns to downstream steps to capture and purify that product, as well ...

Shell’s strategy focuses on cost reductions, increased shareholder returns, and maintaining strong upstream and downstream operations to ensure stability in a volatile energy market. Management is ...